3
Participants
Start Date
July 15, 2010
Primary Completion Date
December 13, 2010
Study Completion Date
December 13, 2010
Treatment
Patients treated with Lapatinib-capecitabine after Trastuzumab progression
GSK Investigational Site, Salvador
GSK Investigational Site, Vitória
GSK Investigational Site, Salvador
GSK Investigational Site, Salvador
GSK Investigational Site, Goiânia
GSK Investigational Site, Goiânia
GSK Investigational Site, Natal
GSK Investigational Site, Porto Alegre
GSK Investigational Site, Florianópolis
GSK Investigational Site, São José dos Campos
GSK Investigational Site, Belo Horizonte
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, São Paulo
Lead Sponsor
GlaxoSmithKline
INDUSTRY